Genome-wide Gene Expression Analysis of Prostate Carcinoma

Seminars in Oncology

Volumn 30, Issue 5, 2003, Pages 635-648

  Gerald, William L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; TUMOR MARKER;

CANCER GENETICS; CANCER HORMONE THERAPY; CANCER INCIDENCE; DIAGNOSTIC ACCURACY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN GENOME; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; REVIEW; TECHNOLOGY;

EID: 0142030958     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00349-X     Document Type: Article

References (35)

1. Ladanyi M, Chan WC, Triche TJ, et al: Expression profiling of human tumors: The end of surgical pathology? J Mol Diagn 3:92-97, 2001
2. Lakhani SR, Ashworth A: Microarray and histopathological analysis of tumours: The future and the past? Nature Rev Cancer 1:151-157, 2001
3. Bertucci F, Houlgatte R, Nguyen C, et al: Gene expression profiling of cancer by use of DNA arrays: How far from the clinic? Lancet Oncol 2:674-682, 2001
4. Alizadeh AA, Ross DT, Perou CM, et al: Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195:41-52, 2001
5. Ramaswamy S, Golub TR: DNA microarrays in clinical oncology. J Clin Oncol 20:1932-1941, 2002
6. Barry M: Prostate specific antigen testing for early diagnosis of prostate cancer. N Engl J Med 344:1373-1377, 2001
7. Oesterling J, Fuks Z, Lee C, et al: Cancer of the prostate, in Devita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 5). Philadelphia, PA, Lippincott-Raven, 1997, pp 1322-186
8. The Chipping Forecast. Nature Genet 21:1-61, 1999 (suppl)
9. Gleason DF: Histologic grading of prostate cancer: A perspective. Hum Pathol 23:273-279, 1992
10. Bostwick DG, Shan A, Qian J, et al: Independent origin of multiple foci of prostatic intraepithelial neoplasia: Comparison with matched foci of prostate carcinoma. Cancer 83:1995-2002, 1998
11. Macintosh CA, Stower M, Reid N, et al: Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 58:223-228, 1998
12. Liu AY, Nelson P, van den Engh G, et al: Human prostate epithelial cell-type cDNA libraries and prostate expression patterns. Prostate 50:92-103, 2002
13. Quackenbush J: Computational analysis of microarray data. Nat Rev Genet 2:418-27, 2001
14. Wheeler DL, Chappey C, Lash AE, et al: Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 28:10-14, 2000
15. Nelson PS, Pritchard C, Abbott D, et al: The human (PEDB) and mouse (mPEDB) prostate expression databases. Nucleic Acids Res 30:218-220, 2002
16. Waghray A, Schober M, Feroze F, et al: Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. Cancer Res 61:4283-4286, 2001
17. LaTulippe E, Satagopan J, Smith A, et al: Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62:4499-4506, 2002
18. Dhanasekaran S, Barrette T, Ghosh D: Delineation of prognostic biomarkers in prostate cancer. Nature 412:822-826, 2001
19. Luo J, Duggan D, Chen Y, et al: Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res 61:4683-4688, 2001
20. Magee J, Araki T, Patil S, et al: Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61:5692-5696, 2001
21. Welsh J, Sapinoso L, Su A, et al: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61:5974-5978, 2001
22. Luo J-H, Yu Y, Cieply K, et al: Gene expression analysis of prostate cancers. Mol Carcino 33:25-35, 2002
23. Singh D, Febbo P, Ross K, et al: Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1:203-209, 2002
24. Stamey T, Warrington J, Caldwell M, et al: Molecular genetic profiling of Gleason grad4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 166:2171-2177, 2001
25. Xu L, Su Y, Labiche R, et al: Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int J Cancer 92:322-328, 2001
26. Nelson P, Han D, Rochon Y, et al: Comprehensive analyses of prostate gene expression: Convergence of expressed sequence tag databases, transcript profiling and proteomics. Electrophoresis 21:1823-1831, 2000
27. Vaarala M, Porvari K, Kyllogen A, et al: Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 80:1259-1268, 2000
28. DePrimo S, Diehn M, Nelson J, et al: Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:0032.1-0032.12, 2002
29. Nelson P, Clegg N, Arnold H, et al: The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99:11890-11895, 2002
30. Bubendorf L, Kolmer M, Kononen J, et al: Hormone therapy failure is human prostate cancer: Analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 91: 1758-1764, 1999
31. Mousses S, Wagner U, Chen Y, et al: Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene 20:6718-6723, 2001
32. Amler L, Agus D, LeDuc C, et al: Deregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R. Cancer Res 60:6134-6141, 2000
33. Holzberlein J, LaTulippe E, Satagopan J, et al: Gene expression alterations associated with androgen ablation therapy of human prostate carcinoma. (in revision)
34. Chugh A, Ray A, Gupta J: Squalene monooxygenase as hypocholesterolemic drug target revisited. Prog Lipid Res 42: 37-50, 2003
35. Steck P, Pershouse M, Jasser S, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362, 1997